Search Within

Yanming Zhang

Formats
  1. Journal Article (96)
  2. Meeting Abstract (92)
  3. Research Letter (11)
  4. Review (3)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (203)
  2. Department of Medicine (125)
  3. Center for Hematologic Malignancies (113)
  4. Hematologic Malignancies, Division of (109)
  5. Sloan Kettering Institute Postdocs (73)
  6. GSK Faculty (71)

More Groups

People
  1. Ahmet Dogan (59)
  2. Mikhail Roshal (58)
  3. Maria Arcila (55)
  4. Wenbin Xiao (49)
  5. Martin Tallman (34)
  6. Ross Levine (30)

More People

Years
  1. 2025 (7)
  2. 2024 (27)
  3. 2023 (29)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (36)

More Years

Publications
  1. Blood (45)
  2. Modern Pathology (23)
  3. Laboratory Investigation (20)
  4. Blood Advances (11)
  5. Genes Chromosomes and Cancer (7)
  6. Nature Communications (6)

More Publications

Publishers
  1. American Society of Hematology (56)
  2. Nature Publishing Group (35)
  3. Nature Research (24)
  4. Elsevier Inc. (13)
  5. Wiley Blackwell (9)
  6. American Association for Cancer Research (7)

More Publishers

Results (203)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Blaney, P.; Ziccheddu, B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Tracking the earliest genomic events in multiple myeloma life-history
    Meeting Abstract

    Cirrincione, A.; Poos, A.; Kaddoura, M.; Ziccheddu, B.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; Papadimitriou, M.; Blaney, P.; Gagler, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
    Research Letter

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Reiner, A. S.; Cimera, R.; Nandakumar, S.; Price, A.; Vanderbilt, C.; Fahy, T.; Young, R. J.; more...
    Acta Neuropathologica (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Cytogenetics and molecular genetics of myelodysplastic neoplasms
    Review

    Ning, Y.; Zhang, Y.; Kallen, M. A.; Emadi, A.; Baer, M. R.
    Best Practice and Research: Clinical Haematology (2023)

    Fulltext@MSK | Save